▲ BUY
8
/ 10
Conviction
$ Value
$43K
Shares
24,000
Price
$2
Filed
Jun 18
▶ Why this score? (8/10)
- ✓ Open market buy (+3)
- ✓ % of holdings >= 20% (+2)
- ✓ Cluster: 4 insiders buying (+2)
- ✓ Not a 10b5-1 plan (+1)
Insider
Name
Wentworth Kerry
Title
CHIEF REGULATORY OFFICER
CIK
0001369453
Roles
Officer
Transaction Details
Transaction Date
2025-06-16
Code
P
Table
Non-Derivative
Ownership
Direct
Equity Swap
No
Shares After
50,000
Filing Info
Wentworth Kerry's History
| Date | Ticker | Type | Value |
|---|---|---|---|
| 2026-04-17 | NUVB | M | $108K |
| 2026-04-17 | NUVB | ▼ | $184K |
| 2026-04-17 | NUVB | M | $0 |
| 2026-04-06 | NUVB | M | $187K |
| 2026-04-06 | NUVB | M | $194K |
| 2026-04-06 | NUVB | ▼ | $904K |
| 2026-04-06 | NUVB | M | $0 |
| 2026-04-06 | NUVB | M | $0 |
| 2026-02-27 | NUVB | A | $0 |
| 2025-06-16 | NUVB | ▲ | $47K ★ |
Other Insiders at NUVB (90d)
| Insider | Bought | Sold | Last |
|---|---|---|---|
|
Hung David
PRESIDENT AND CEO
|
— | — | 2026-02-27 |
|
Wentworth Kerry
CHIEF REGULATORY OFFICER
|
— | $1.1M | 2026-04-17 |
| Cui Xiangmin | — | — | 2026-02-27 |
|
Hattersley Gary
CHIEF SCIENTIFIC OFFICER
|
— | — | 2026-02-27 |
|
Markel Stacy
CHIEF PEOPLE OFFICER
|
— | — | 2026-02-27 |
|
Hanley David C.
CHIEF TECHNICAL OPERATIONS
|
— | — | 2026-02-27 |
|
Liu Dongfang
CHIEF MEDICAL OFFICER
|
— | $251K | 2026-04-17 |
|
Makunje Moses
SEE REMARKS
|
— | — | 2026-02-27 |
|
Sjogren Colleen
Chief Commercial Officer
|
— | — | 2026-02-27 |
|
Sauvage Philippe
Chief Financial Officer
|
— | — | 2026-02-27 |